vs
Orthofix Medical Inc.（OFIX）与Via Renewables, Inc.（VIASP）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Via Renewables, Inc.的1.7倍（$219.9M vs $127.8M），Via Renewables, Inc.净利率更高（5.4% vs -1.0%，领先6.4%），Via Renewables, Inc.同比增速更快（22.5% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-4.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 5.9%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
EDF电力解决方案是法国电力集团旗下全资子公司，专注可再生能源发电业务。作为一体化运营商，该集团开展可再生能源项目开发与融资，推进设施建设，同时为自有及第三方的可再生能源项目提供运营与维护服务。
OFIX vs VIASP — 直观对比
营收规模更大
OFIX
是对方的1.7倍
$127.8M
营收增速更快
VIASP
高出20.5%
2.0%
净利率更高
VIASP
高出6.4%
-1.0%
自由现金流更多
OFIX
多$21.6M
$-4.8M
两年增速更快
OFIX
近两年复合增速
5.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $127.8M |
| 净利润 | $-2.2M | $6.9M |
| 毛利率 | 71.1% | 34.4% |
| 营业利润率 | 0.2% | 15.2% |
| 净利率 | -1.0% | 5.4% |
| 营收同比 | 2.0% | 22.5% |
| 净利润同比 | 92.4% | -30.9% |
| 每股收益（稀释后） | $-0.05 | $1.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXVIASP
| Q4 25 | $219.9M | $127.8M | ||
| Q3 25 | $205.6M | $103.3M | ||
| Q2 25 | $203.1M | $90.0M | ||
| Q1 25 | $193.6M | $142.3M | ||
| Q4 24 | $215.7M | $104.3M | ||
| Q3 24 | $196.6M | $93.8M | ||
| Q2 24 | $198.6M | $86.7M | ||
| Q1 24 | $188.6M | $114.1M |
净利润OFIXVIASP
| Q4 25 | $-2.2M | $6.9M | ||
| Q3 25 | $-22.8M | $757.0K | ||
| Q2 25 | $-14.1M | $2.7M | ||
| Q1 25 | $-53.1M | $8.8M | ||
| Q4 24 | $-29.1M | $9.9M | ||
| Q3 24 | $-27.4M | $2.1M | ||
| Q2 24 | $-33.4M | $7.6M | ||
| Q1 24 | $-36.0M | $8.6M |
毛利率OFIXVIASP
| Q4 25 | 71.1% | 34.4% | ||
| Q3 25 | 72.2% | 23.1% | ||
| Q2 25 | 68.7% | 30.0% | ||
| Q1 25 | 62.8% | 32.9% | ||
| Q4 24 | 69.0% | 51.9% | ||
| Q3 24 | 68.7% | 26.8% | ||
| Q2 24 | 67.8% | 50.4% | ||
| Q1 24 | 67.5% | 39.5% |
营业利润率OFIXVIASP
| Q4 25 | 0.2% | 15.2% | ||
| Q3 25 | -8.3% | 3.1% | ||
| Q2 25 | -7.9% | 6.7% | ||
| Q1 25 | -25.2% | 17.5% | ||
| Q4 24 | -5.3% | 31.5% | ||
| Q3 24 | -9.6% | 5.3% | ||
| Q2 24 | -12.5% | 23.8% | ||
| Q1 24 | -15.6% | 22.6% |
净利率OFIXVIASP
| Q4 25 | -1.0% | 5.4% | ||
| Q3 25 | -11.1% | 0.7% | ||
| Q2 25 | -6.9% | 3.0% | ||
| Q1 25 | -27.4% | 6.2% | ||
| Q4 24 | -13.5% | 9.5% | ||
| Q3 24 | -13.9% | 2.3% | ||
| Q2 24 | -16.8% | 8.8% | ||
| Q1 24 | -19.1% | 7.5% |
每股收益（稀释后）OFIXVIASP
| Q4 25 | $-0.05 | $1.19 | ||
| Q3 25 | $-0.57 | $-0.41 | ||
| Q2 25 | $-0.36 | $0.09 | ||
| Q1 25 | $-1.35 | $1.83 | ||
| Q4 24 | $-0.76 | $2.33 | ||
| Q3 24 | $-0.71 | $-0.17 | ||
| Q2 24 | $-0.88 | $1.51 | ||
| Q1 24 | $-0.95 | $1.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $41.8M |
| 总债务越低越好 | — | $120.0M |
| 股东权益账面价值 | $450.0M | $67.7M |
| 总资产 | $850.6M | $331.3M |
| 负债/权益比越低杠杆越低 | — | 1.77× |
8季度趋势，按日历期对齐
现金及短期投资OFIXVIASP
| Q4 25 | $82.0M | $41.8M | ||
| Q3 25 | $62.9M | $53.6M | ||
| Q2 25 | $65.6M | $62.1M | ||
| Q1 25 | $58.0M | $64.7M | ||
| Q4 24 | $83.2M | $53.1M | ||
| Q3 24 | $30.1M | $66.6M | ||
| Q2 24 | $26.4M | $53.6M | ||
| Q1 24 | $27.0M | $50.4M |
总债务OFIXVIASP
| Q4 25 | — | $120.0M | ||
| Q3 25 | $157.2M | $105.0M | ||
| Q2 25 | $157.0M | $100.0M | ||
| Q1 25 | $156.9M | $101.0M | ||
| Q4 24 | $157.0M | $106.0M | ||
| Q3 24 | $118.5M | $89.0M | ||
| Q2 24 | $118.0M | $93.0M | ||
| Q1 24 | $118.2M | $91.0M |
股东权益OFIXVIASP
| Q4 25 | $450.0M | $67.7M | ||
| Q3 25 | $442.5M | $63.7M | ||
| Q2 25 | $458.3M | $68.2M | ||
| Q1 25 | $458.3M | $72.7M | ||
| Q4 24 | $503.1M | $66.7M | ||
| Q3 24 | $525.9M | $58.2M | ||
| Q2 24 | $546.0M | $58.3M | ||
| Q1 24 | $570.3M | $53.2M |
总资产OFIXVIASP
| Q4 25 | $850.6M | $331.3M | ||
| Q3 25 | $832.6M | $304.8M | ||
| Q2 25 | $837.2M | $316.3M | ||
| Q1 25 | $823.1M | $347.4M | ||
| Q4 24 | $893.3M | $344.9M | ||
| Q3 24 | $867.9M | $298.4M | ||
| Q2 24 | $882.0M | $299.7M | ||
| Q1 24 | $906.0M | $302.7M |
负债/权益比OFIXVIASP
| Q4 25 | — | 1.77× | ||
| Q3 25 | 0.36× | 1.65× | ||
| Q2 25 | 0.34× | 1.47× | ||
| Q1 25 | 0.34× | 1.39× | ||
| Q4 24 | 0.31× | 1.59× | ||
| Q3 24 | 0.23× | 1.53× | ||
| Q2 24 | 0.22× | 1.60× | ||
| Q1 24 | 0.21× | 1.71× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-4.2M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-4.8M |
| 自由现金流率自由现金流/营收 | 7.6% | -3.7% |
| 资本支出强度资本支出/营收 | 4.9% | 0.4% |
| 现金转化率经营现金流/净利润 | — | -0.61× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $39.1M |
8季度趋势，按日历期对齐
经营现金流OFIXVIASP
| Q4 25 | $27.7M | $-4.2M | ||
| Q3 25 | $12.4M | $2.4M | ||
| Q2 25 | $11.6M | $19.0M | ||
| Q1 25 | $-18.4M | $24.9M | ||
| Q4 24 | $23.7M | $2.0M | ||
| Q3 24 | $11.7M | $20.1M | ||
| Q2 24 | $9.0M | $11.2M | ||
| Q1 24 | $-18.6M | $17.1M |
自由现金流OFIXVIASP
| Q4 25 | $16.8M | $-4.8M | ||
| Q3 25 | $2.5M | $1.9M | ||
| Q2 25 | $4.5M | $18.4M | ||
| Q1 25 | $-25.1M | $23.5M | ||
| Q4 24 | $15.2M | $1.6M | ||
| Q3 24 | $6.3M | $19.7M | ||
| Q2 24 | $-360.0K | $10.9M | ||
| Q1 24 | $-29.1M | $16.6M |
自由现金流率OFIXVIASP
| Q4 25 | 7.6% | -3.7% | ||
| Q3 25 | 1.2% | 1.9% | ||
| Q2 25 | 2.2% | 20.5% | ||
| Q1 25 | -13.0% | 16.5% | ||
| Q4 24 | 7.0% | 1.5% | ||
| Q3 24 | 3.2% | 21.0% | ||
| Q2 24 | -0.2% | 12.6% | ||
| Q1 24 | -15.4% | 14.6% |
资本支出强度OFIXVIASP
| Q4 25 | 4.9% | 0.4% | ||
| Q3 25 | 4.8% | 0.4% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 3.5% | 1.0% | ||
| Q4 24 | 4.0% | 0.4% | ||
| Q3 24 | 2.7% | 0.4% | ||
| Q2 24 | 4.7% | 0.3% | ||
| Q1 24 | 5.6% | 0.4% |
现金转化率OFIXVIASP
| Q4 25 | — | -0.61× | ||
| Q3 25 | — | 3.12× | ||
| Q2 25 | — | 6.94× | ||
| Q1 25 | — | 2.84× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 9.41× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 2.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
VIASP
| Retail Electricity | $79.7M | 62% |
| Retail Natural Gas | $48.9M | 38% |
